β-amyloid peptides decrease soluble guanylyl cyclase expression in astroglial cells

Neurobiology of Disease

Volumn 10, Issue 2, 2002, Pages 139-149

  Baltrons, María Antonia ^a   Pedraza, Carlos E ^a   Heneka, Michael T ^b   García, Agustina ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b UNIVERSITY OF BONN   (Germany)

Author keywords

Astroglial; Cyclic GMP; Nitric oxide; Soluble guanylyl cyclase; amyloid peptides

Indexed keywords

AMYLOID BETA PROTEIN; CYCLIC GMP; CYCLOHEXIMIDE; GAMMA INTERFERON; GUANYLATE CYCLASE; MESSENGER RNA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CELL LOSS; CEREBELLUM; CONTROLLED STUDY; ENZYME INHIBITION; HIPPOCAMPUS; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION;

EID: 0036077251     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1006/nbdi.2002.0492     Document Type: Article

References (51)

1. Increased density of metallothionein I/II-immunopositive cortical glial cells in the early stages of Alzheimer's disease
2. Beta-Amyloid stimulation of inducible nitric oxide synthase in astrocytes is interleukin-1β- and tumor necrosis factor-α (TNF-α)-dependent, and involves a TNF-α receptor-associated factor-and NFkappaB-inducing kinase-dependent signalling mechanism
3. β-Amyloid stimulates glial cells in vitro to produce growth factors that accumulate in senile plaques in Alzheimer's disease
4. Characterization of noradrenaline-stimulated cyclic GMP formation in brain astrocytes in culture
5. Calcium-dependent nitric oxide formation in glial cells
6. 2+/calmodulin dependent cyclic GMP phosphodiesterase activity in granule neurons and astrocytes from cerebellum
7. Regulation by calcium of the nitric oxide/cyclic GMP system in cerebellar granule cells and astroglia in culture
8. Nitric oxide-independent down-regulation of soluble guanylyl cyclase by bacterial endotoxin in astroglial cells
9. The nitric oxide/cyclic GMP system in astroglial cells
10. Reduced nitric oxide responsive soluble guanylyl cyclase activity in the superior temporal cortex of patients with Alzheimer's disease
11. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
12. Radioimmunoassay of cyclic AMP and cyclic GMP
13. Expression of soluble guanylate cyclase activity requires both enzyme subunits
14. Gluthatione metabolism in brain
15. Molecular profile of reactive astrocytes-implications for their role in neurologic disease
16. Nitric oxide decreases stability of mRNAs encoding soluble guanylate cyclase subunits in rat pulmonary artery smooth muscle cells
17. Expressional control of the 'constitutive' isoforms of nitric oxide synthase (NOS I and NOS III)
18. Nitric oxide signalling in the central nervous system
19. Subunits of the nitric oxide receptor, soluble guanylyl cyclase, expressed in rat brain
20. Microglia as mediators of inflammatory and degenerative diseases
21. Microglial release of nitric oxide by the synergistic action of beta-amyloid and INF-gamma
22. The shaping of nitric oxide signals by a cellular sink
23. Similar activation of glial cultures from different rat brain regions by neuroinflammatory stimuli and downregulation of the activation by a new class of small molecule ligands
24. Expression of soluble guanylyl cyclase. Catalytic activity requires two enzyme subunits
25. Chronic neuroinflammation in rats reproduces components of the neurobiology of Alzheimer's disease
26. Peroxixome proliferator-activated receptor-γ ligands reduce neuronal inducible nitric oxide synthase expression and cell death in vivo
27. Amyloid-β peptide activates cultured astrocytes: Morphological alterations, cytokine induction and nitric oxide release
28. Bacterial endotoxin-induced expression of metallothionein genes in rat brain, as revealed by in situ hybridization
29. β-Amyloid protein enhances macrophage production of oxygen free radicals and glutamate
30. Nitric oxide protects PC12 cells from serum deprivation-induced apoptosis by cGMP-dependent inhibition of caspase signalling
31. 2+]i in rat astrocytes
32. Nerve growth factor decreases soluble guanylate cyclase in rat pheochromocytoma PC12 cells
33. Protein measurements with the folin phenol reagent
34. Activation of microglial cells by β-amyloide protein and interferon-γ
35. Mechanisms of tolerance to sodium nitroprusside in cultured rat aortic smooth muscle cells
36. Downregulation of nitro-vasodilator-induced cyclic GMP accumulation in cells exposed to endotoxin or interleukin-1β
37. Evidence of oxidative stress and in vivo neurotoxicity of beta-amyloid in a transgenic mouse model of Alzheimer's disease: A chronic oxidative paradigm for testing antioxidant therapies in vivo
38. Inhibition of Alzheimer's β-Amyloid induced vasoactivity and proinflammatory response in microglia by a cGMP-dependent mechanism
39. Bregma, lambda and the interaural midpoint in stereotaxic surgery with rats of different sex, strain and weight
40. β-Amyloide-induced changes in cultured astrocytes parallel reactive astrocytosis associated with senile plaques in Alzheimer's disease
41. Early association of reactive astrocytes with senile plaques in Alzheimer's disease
42. Synergistic induction of nitric oxide by β-amyloid and cytokines in astrocytes
43. β-Amyloid peptide induced cytoskeletal reorganization in cultured astrocytes
44. Widespread peroxynitrite-mediated damage in Alzheimer's disease
45. Cytokines decrease sGC in pulmonary artery smooth muscle cells via NO-dependent and NO-independent mechanisms
46. Attenuation of sodium nitroprusside responses after prolonged incubation of rat aorta with endotoxin
47. Homologous and heterologous desensitization of a guanylyl cyclase-linked nitric oxide receptor in cultured rat medullar interstitial cells
48. Nitric oxide synthase in reactive astrocytes adjacent to β-amyloid plaques
49. Metallothioneins are highly expressed in astrocytes and micropillaries in Alzheimer's disease
50. Nitric oxide selectively release metals from the N-terminal domain of metallothioneins: Potential role at inflammatory sites
51. Nitric oxide in the nervous system